• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Brent Passer

Publications

  • Castelo-Branco P, Passer BJ, Buhrman JS, Antoszczyk S, Marinelli M, Zaupa C, Rabkin SD, Martuza RL.Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.Gene Ther. 2010 Jun;17(6):805-10.
    20220784
  • Passer BJ, Cheema T, Zhou B, Wakimoto H, Zaupa C, Razmjoo M, Sarte J, Wu S, Wu CL, Noah JW, Li Q, Buolamwini JK, Yen Y, Rabkin SD, Martuza RL.Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.Cancer Res. 2010 May 15;70(10):3890-5.
    20424118
  • Castelo-Branco P, Passer BJ, Buhrman JS, Antoszczyk S, Marinelli M, Zaupa C, Rabkin SD, Martuza .An oncolytic herpes simplex virus armed with a xenogeneic homologue of prostatic acid phosphatase enhances anti-tumor efficacy in prostate cancer .Gene Ther..
  • Fulci G, Passer B.Analysis of HSV oncolytic virotherapy in organotypic cultures.Methods Mol Biol. 2009;542:75-86.
    19565896
  • Passer BJ, Castelo-Branco P, Buhrman JS, Varghese S, Rabkin SD, Martuza RL.Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.Cancer Gene Ther. 2009 Jul;16(7):551-60.
    19197321